ArticleMolecular oncology2021

KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer.

Sofia Mastoraki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.